Ticks aren’t all bad! Check out the Business of Biotech podcast to hear how Akari engineered #nomacopan, a recombinant protein derived from ticks, and scaled manufacturing for clinical trials and beyond. Listen to the podcast here: https://lnkd.in/eU6QAHv7
